title: Chromosome missegregation causes colon cancer by APC loss of heterozygosity.
abstract: A longstanding hypothesis in the field of cancer biology is that aneuploidy causes cancer by promoting loss of chromosomes that contain tumor suppressor genes. By crossing aneuploidyprone Bub1 hypomorphic mice onto a heterozygous null background for p53, we provided conclusive evidence for this idea.(1) Surprisingly, the tumors that developed in this model had not just lost the chromosome 11 copy harboring wild-type p53, but had also gained an extra copy of chromosome 11 bearing the p53 null allele. Here we report that a similar chromosome-reshuffling blueprint drives colonic tumorigenesis in Bub1 hypomorphic mice that are heterozygous for Apc(Min), but now involving chromosome 18. These extended studies highlight that in order for whole chromosome instability to drive tumorigenesis, it needs to establish tumor suppressor gene loss of heterozygosity while retaining two copies of the other genes on the chromosome. Additional restrictions seem to apply to whole chromosome instability as a cancer causing mechanism, which will be discussed in this paper.
authors.affiliation: Departments of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
authors.forename: Darren J
authors.initials: DJ
authors.lastname: Baker
authors.forename: Jan M
authors.initials: JM
authors.lastname: van Deursen
mesh_terms: D000782:Aneuploidy; D000818:Animals; D043171:Chromosomal Instability; D020090:Chromosome Segregation; D003110:Colonic Neoplasms / Q000235:genetics*; D017491:Genes, APC; D006579:Heterozygote; D019656:Loss of Heterozygosity; D051379:Mice; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
chemical_list: D016159:Tumor Suppressor Protein p53; C584281:Bub1 protein, mouse; C090464:Bub1 spindle checkpoint protein; D017346:Protein Serine-Threonine Kinases
references.citation: Sci Am. 2007 May;296(5):52-9
references.pmid: 17500414
references.citation: Cancer Cell. 2007 Jan;11(1):25-36
references.pmid: 17189716
references.citation: Nature. 1992 Sep 24;359(6393):295-300
references.pmid: 1406933
references.citation: Oncogene. 1994 Apr;9(4):1021-7
references.pmid: 8134105
references.citation: J Cell Biol. 2009 Jun 15;185(6):935-7
references.pmid: 19528293
references.citation: Science. 2008 Oct 31;322(5902):703-9
references.pmid: 18974345
references.citation: EMBO J. 2005 Apr 20;24(8):1621-33
references.pmid: 15933723
references.citation: Cancer Res. 2007 Jan 1;67(1):160-6
references.pmid: 17210695
references.citation: Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1563-8
references.pmid: 9990064
references.citation: Cell Cycle. 2006 Feb;5(4):366-70
references.pmid: 16479161
references.citation: J Cell Biol. 2007 Oct 22;179(2):255-67
references.pmid: 17938250
references.citation: Mol Endocrinol. 2001 Nov;15(11):1870-9
references.pmid: 11682618
references.citation: Curr Biol. 1994 Jan 1;4(1):1-7
references.pmid: 7922305
references.citation: J Cell Biol. 2006 Feb 13;172(4):529-40
references.pmid: 16476774
references.citation: Cell Cycle. 2003 May-Jun;2(3):202-10
references.pmid: 12734426
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16719-24
references.pmid: 18940925
references.citation: J Cell Biol. 2003 Feb 3;160(3):341-53
references.pmid: 12551952
references.citation: Semin Cancer Biol. 2005 Feb;15(1):43-9
references.pmid: 15613287
references.citation: Curr Biol. 2003 Nov 11;13(22):1979-84
references.pmid: 14614824
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4365-70
references.pmid: 15767571
references.citation: Trends Genet. 2008 Sep;24(9):457-66
references.pmid: 18675487
references.citation: Cancer Cell. 2009 Dec 8;16(6):475-86
references.pmid: 19962666
references.citation: Cancer Res. 2007 Nov 1;67(21):10103-5
references.pmid: 17974949
references.citation: Nat Rev Mol Cell Biol. 2009 Jul;10(7):478-87
references.pmid: 19546858
references.citation: J Cell Sci. 2008 Jan;121 Suppl 1:1-84
references.pmid: 18089652
references.citation: Nat Rev Cancer. 2010 Feb;10(2):102-15
references.pmid: 20094045
references.citation: Anticancer Res. 1999 Nov-Dec;19(6A):4887-906
references.pmid: 10697602
references.citation: Cell Cycle. 2005 Sep;4(9):1171-5
references.pmid: 16082216
references.citation: Curr Opin Cell Biol. 2005 Dec;17(6):583-9
references.pmid: 16226453
references.citation: Cancer Cell. 2009 Dec 8;16(6):451-2
references.pmid: 19962661
references.citation: Nat Genet. 2004 Jul;36(7):744-9
references.pmid: 15208629
references.citation: Nat Genet. 2006 Sep;38(9):1043-8
references.pmid: 16921376
references.citation: Cancer Cell. 2007 Jan;11(1):9-23
references.pmid: 17189715
references.citation: Dev Cell. 2007 Oct;13(4):566-79
references.pmid: 17925231
references.citation: Nature. 2001 Jan 18;409(6818):355-9
references.pmid: 11201745
references.citation: Genetics. 2008 Jun;179(2):737-46
references.pmid: 18558649
references.citation: Science. 2007 Aug 17;317(5840):916-24
references.pmid: 17702937